Consensus clinical management guidelines for Niemann-Pick disease type C.

Geberhiwot, Tarekegn and Moro, Alessandro and Dardis, Andrea and Ramaswami, Uma and Sirrs, Sandra and Marfa, Mercedes Pineda and Vanier, Marie T and Walterfang, Mark and Bolton, Shaun and Dawson, Charlotte and Héron, Bénédicte and Stampfer, Miriam and Imrie, Jackie and Hendriksz, Christian and Gissen, Paul and Crushell, Ellen and Coll, Maria J and Nadjar, Yann and Klünemann, Hans and Mengel, Eugen and Hrebicek, Martin and Jones, Simon A and Ory, Daniel and Bembi, Bruno and Patterson, Marc (2018) Consensus clinical management guidelines for Niemann-Pick disease type C. Orphanet journal of rare diseases, 13 (1). p. 50. ISSN 1750-1172. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs

[img]
Preview
Text (Article opens in PDF file format)
Consensus clinical management guidelines for Niemann-Pick disease type C.pdf - Published Version
Available under License Creative Commons Attribution.

Download (938kB) | Preview
Official URL: https://ojrd.biomedcentral.com/articles/10.1186/s1...

Abstract

Niemann-Pick Type C (NPC) is a progressive and life limiting autosomal recessive disorder caused by mutations in either the NPC1 or NPC2 gene. Mutations in these genes are associated with abnormal endosomal-lysosomal trafficking, resulting in the accumulation of multiple tissue specific lipids in the lysosomes. The clinical spectrum of NPC disease ranges from a neonatal rapidly progressive fatal disorder to an adult-onset chronic neurodegenerative disease. The age of onset of the first (beyond 3 months of life) neurological symptom may predict the severity of the disease and determines life expectancy.NPC has an estimated incidence of ~ 1: 100,000 and the rarity of the disease translate into misdiagnosis, delayed diagnosis and barriers to good care. For these reasons, we have developed clinical guidelines that define standard of care for NPC patients, foster shared care arrangements between expert centres and family physicians, and empower patients. The information contained in these guidelines was obtained through a systematic review of the literature and the experiences of the authors in their care of patients with NPC. We adopted the Appraisal of Guidelines for Research & Evaluation (AGREE II) system as method of choice for the guideline development process. We made a series of conclusive statements and scored them according to level of evidence, strengths of recommendations and expert opinions. These guidelines can inform care providers, care funders, patients and their carers of best practice of care for patients with NPC. In addition, these guidelines have identified gaps in the knowledge that must be filled by future research. It is anticipated that the implementation of these guidelines will lead to a step change in the quality of care for patients with NPC irrespective of their geographical location.

Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
Subjects: WK Endocrine system. Endocrinology
Divisions: Ambulatory Care > Diabetes
Related URLs:
Depositing User: Mrs Semanti Chakraborty
Date Deposited: 29 Mar 2019 15:26
Last Modified: 29 Mar 2019 15:26
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/1979

Actions (login required)

View Item View Item